Bozhi Anjian (Hebei) Pharmaceutical Co., Ltd.

The main purpose of the study: After a single dose of pediatric faropenem sodium granules was taken orally on an empty stomach or after meals, the in vivo kinetics of faropenem sodium was observed, the corresponding pharmacokinetic parameters were estimated, and bioequivalence evaluation was performed. Secondary purpose of the study: To observe the safety of the test preparation pediatric faropenem sodium granules and the reference preparation pediatric faropenem sodium granules (Firom) in healthy subjects.